News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
Presentation EuroPCR 2024 Short Methodology Insight - NOTION-2 Presenter: Davide Capodanno May 14, 2024
News Daily News Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA Michael O'Riordan March 14, 2024